Renal safety of ibandronate in patients with renal deterioration and multiple myeloma

被引：0
|
作者：
Raoul, R
Henrich, DM
Hoffmann, M
Ullmann, M
Honecker, A
Nagel, D
Uppenkamp, M
机构：
[1] Klinikum Stadt Ludwigshafen gGmbH, Med Klin A, Ludwigshafen, Germany
[2] Klinikum Stadt Ludwigshafen gGmbH, Inst Klin Chem, Ludwigshafen, Germany
[3] MDS Pharma Serv, Zurich, Switzerland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V100 / V101
页数：2
相关论文
共 50 条
  • [1] Renal safety of ibandronate in multiple myeloma patients with renal deterioration
    Bergner, R
    Henrich, DM
    Hoffmann, M
    Ullmann, M
    Honecker, A
    Nagel, D
    Uppenkamp, M
    CANCER TREATMENT REVIEWS, 2005, 31 : S45 - S45
  • [2] Renal safety of ibandronate in patients with relapsed and refractory multiple myeloma
    Glasmacher, A
    Hoffmann, F
    Orlopp, K
    von Lilienfeld-Toal, M
    Hahn, C
    BONE, 2006, 38 (03) : S73 - S73
  • [3] Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function
    Bergner, Raoul
    Henrich, Dirk M.
    Hoffmann, Martin
    Honecker, Andrea
    Mikus, Gerd
    Nauth, Bettina
    Nagel, Dietmar
    Uppenkamp, Michael
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (08): : 942 - 950
  • [4] Renal safety of ibandronate in the treatment of myeloma patients
    Breuer, J.
    Uppenkamp, M.
    Sandermann, A.
    Hoffmann, M.
    Bergner, R.
    ONKOLOGIE, 2010, 33 : 157 - 157
  • [5] Renal safety of ibandronate in the treatment of myeloma patients
    Bergner, Raoul
    Jochen, Breuer
    Uppenkamp, Michael
    Sandermann, Andreas
    Hoffmann, Martin
    BONE, 2010, 46 : S35 - S35
  • [6] Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with pre-existing renal insufficiency
    Bergner, R.
    Nauth, B.
    Henrich, D. M.
    Hoffmann, M.
    Ullmann, M.
    Honecker, A.
    Nagel, D.
    Uppenkamp, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 206 - 206
  • [7] Ibandronate in patients with multiple myeloma and renal insufficiency: Pharmacokinetics and tolerability
    Bergner, R.
    Nauth, B.
    Henrich, D. M.
    Hoffmann, M.
    Ullmann, M.
    Honecker, A.
    Nagel, D.
    Uppenkamp, M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S35 - S35
  • [8] Renal compatibility in Ibandronate therapy in patients with multiple myeloma and different stages of renal function.
    Bergner, R.
    Breuer, J.
    Uppenkamp, M.
    Sandermann, A.
    Hoffmann, M.
    ONKOLOGIE, 2010, 33 : 191 - 191
  • [9] COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients
    Knauf, W.
    Bergner, R.
    Kropff, M.
    Poenisch, W.
    Kiewitz, C.
    Goldschmidt, H.
    ONKOLOGIE, 2010, 33 : 246 - 246
  • [10] COMPARE - RESULTS OF A RANDOMISED STUDY TO ASSESS THE RENAL SAFETY AND EFFICACY OF IBANDRONATE AND ZOLEDRONATE IN MULTIPLE MYELOMA PATIENTS
    Knauf, U.
    Bergner, R.
    Kropff, M.
    Poenisch, W.
    Kiewitz, C.
    Goldschmidts, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 398 - 398
12345